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Objective: Surgical treatment of intact thoracoabdominal aortic aneurysm (TAAA) is crucial to prevent rupture but is
associated with high perioperative mortality. We tested the hypothesis that provider volume of surgical treatment of
TAAA is an important determinant of operative outcome.
Patients and methods: Clinical information regarding repair of intact TAAA in 1542 patients from 1988 to 1998 was
obtained from the Nationwide Inpatient Sample (NIS), a stratified discharge database of a representative 20% of US
hospitals. Demographic data included age, sex, race, nature of admission, and comorbid conditions. Annual hospital
volume of TAAA treated was grouped into terciles and defined as low (LVH; 1-3 cases [median, 1]), medium (MVH; 2-9
cases [median, 4]), or high (HVH; 5-31 cases [median, 12]). Annual surgeon volume was defined as low (LVS; 1-2 cases
[median, 1]) or high (HVS; 3-18 cases [median, 7]). The primary outcome measure was in-hospital postoperative
mortality. Secondary outcome measures included length of stay, and cardiac, pulmonary, and renal complications.
Adjusted and unadjusted analyses were conducted.
Results: Overall mortality was 22.3%. Mortality improved over time. LVH and HVH differed in mortality rates (27.4% vs
15.0%; P < .001). Mortality between LVS and HVS also differed significantly (25.6% vs 11.0%; P < .001). When
controlling for patient demographic data, comorbid conditions, and postoperative complications, both hospital and
surgeon volume were significant predictors of mortality for intact TAAA repair (LVS: odds ratio [OR] 2.6, P < .001;
LVH: OR 2.2, P < .001; and MVH: OR 1.7, P  .004).
Conclusions: Greater hospital and surgeon TAAA treatment volumes contribute to better outcome. Given the relative high
perioperative mortality associated with TAAA repair, regionalization of care to high-volume providers with consistently
lower postoperative mortality deserves consideration by patients, physicians, and health care planners. (J Vasc Surg
2003;37:1169-74.)
Thoracoabdominal aortic aneurysm (TAAA) is rare but
potentially lethal. Prospectively gathered natural history
data for patients with untreated TAAA suggest an overall
rate of rupture of 26%, with increasing age, presence of
pain, chronic obstructive pulmonary disease, and large an-
eurysm diameter increasing the risk for rupture.1 Perioper-
ative mortality after repair of intact TAAA at large institu-
tions ranges from 4% to 16%,2-8 and overall national data
suggest a mortality rate approaching 20%.9 Furthermore,
postoperative complications are often severe and include
acute renal failure, paraplegia, myocardial ischemia, myo-
cardial infarction, and prolonged ventilation.
Provider caseload volume has a significant effect on the
variation in postoperative mortality and complications.10,11
As a result, policies of regionalization have been explored
for such procedures as coronary artery bypass grafting,
carotid endarterectomy, esophagectomy, and abdominal
aortic aneurysm (AAA) repair.12 Although TAAA repair is
much less common than other procedures considered for
regionalization, the benefits of selective referral to high-
volume providers may be significant because of the high
procedure-related morbidity and mortality.
The objective of the present study was to test the
hypothesis that provider volume of surgical treatment of
TAAA in a nationally representative sample is an important
determinant of outcome.
METHODS
Data source. Clinical data were derived from the Na-
tionwide Inpatient Sample (NIS) for 1988 to 1998.13 The
NIS is a 20% random sample of US hospitals stratified by
geographic region, teaching status, hospital size, and other
characteristics. Participating hospitals provide 100% of their
discharge abstracts for a particular calendar year. The data-
base is maintained by the Agency for Health Care Research
and Quality as part of the Healthcare Cost and Utilization
Project.
TAAA repair was coded according to the International
classification of diseases, ninth revision, Clinical modifica-
tion (ICD-9-CM), and included ICD-9-CM 384.4, resec-
tion and replacement of the abdominal aorta, and ICD-
9-CM 384.5, resection and replacement of the thoracic
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aorta.9,14 These codes yielded a total of 2185 TAAAs. Then
1542 intact TAAAs were identified, with one of the follow-
ing ICD-9-CM codes: 441.0, aortic aneurysm; 441.2, tho-
racic aortic aneurysm; 441.4, AAA; 441.7, TAAA without
rupture; or 441.9, aortic aneurysm, not otherwise specified.
TAAAs were excluded from the study if the diagnosis
indicated aortic dissection (ICD-9-CM codes 441.00-
441.03, dissecting thoracic or abdominal aneurysm) or
rupture (ICD-9-CM codes 441.1, ruptured thoracic aneu-
rysm; 441.3, ruptured AAA; 441.5, ruptured AAA, not
otherwise specified; or 441.6, ruptured TAAA).
Data regarding age, gender, race, nature of admission,
comorbid conditions, unique hospital identifier, unique
surgeon identifier, vital status at discharge, length of stay
(LOS), and postoperative complications were obtained di-
rectly from the database. Patient age was defined as less
than 65 years or as 65 years or older. Race was categorized
as white or nonwhite. Urgent and emergent admission
were combined and defined as emergent; all other admis-
sion types were considered elective. Comorbid conditions
were determined with the Romano modification of the
Charlson comorbidity index.15,16 Total burden of comor-
bid disease was represented as the sum of all comorbid
conditions and reported as comorbidity score (0, 1, 2,3).
Volume variables. Among TAAA repairs studied,
100% had a unique hospital identifier and 55.7% had a
unique surgeon identifier (some hospitals do not permit
release of any type of surgeon identifier). With these vari-
ables, total annual TAAA experience could be determined.
Hospital volume was considered low (LVH), medium
(MVH), or high (HVH) on the basis of volume terciles.
Surgeon volume was considered low (LVS) or high (HVS)
on the basis of the 50th percentile for annual volume. These
determinations were made for each calendar year, to con-
trol for influence of time when investigating the effect of
provider volume on outcome. Annual TAAA repair volume
was 1 to 3 (median, 1) for LVH, 2 to 9 (median, 4) for
MVH, and 5 to 31 (median, 12) for HVH. Annual TAAA
repair volume was 1 to 2 (median, 1) for LVS and 3 to 18
(median, 7) for HVS. Overlapping ranges are due to vari-
ation from year-to-year absolute caseload volume. Seventy-
two percent of HVS were also in HVH. Ninety-eight
percent of HVS were found in either HVH or MVH.
Specific hospital level data, as defined by the NIS, were
obtained from the database to further define hospital vol-
ume groups (Table I), and included teaching status, size
according to number of beds, and geographic location.
Teaching status was coded as teaching or nonteaching.
Hospital size (number of beds) was defined as small, me-
dium, or large. Geographic location was described as
Northeast, Midwest, South, or West. HVH were more
often large teaching hospitals, compared with MVH or
LVH. No significant geographic variation was noted be-
tween volume groups.
Outcome variables. The primary outcome variable was
in-hospital postoperative mortality. Secondary outcome mea-
sures were LOS and postoperative complications. LOS was
adjusted to reflect postoperative hospital stay by subtracting
hospital day number of the procedure from total LOS. Total
burden of postoperative complications was tabulated with
ICD-9-CM codes 996.0 to 999.0. Specific cardiac (997.1),
pulmonary (997.3), urinary (997.5), and hemorrhagic
(998.1, 998.11) complications, as well as renal failure (584.0,
acute renal failure; 584.6, acute renal failure, cortical necrosis;
584.8, acute renal failure, not elsewhere classifiable; 584.9,
acute renal failure, not otherwise specified; or 788.5, oliguria
or annuria) were also analyzed.
Statistical analysis. Descriptive statistics for patient
characteristics by provider volume were conducted. Uni-
variate comparisons of provider volume, patient character-
istics, calendar year, and outcome variables were performed
with the 2 test, analysis of variance, Kruskal-Wallis test,
and simple linear regression, where appropriate. Stepwise
binary logistic regression (inclusion threshold, P  .1) of
in-hospital mortality was used to test its association with
provider volume after adjusting for potentially confound-
ing patient case-mix variables and postoperative complica-
Table I. Characteristics of US hospitals with varying TAAA repair volume
Annual hospital TAAA repair volume (median number of operations)
Total Low (1) Medium (4) High (12) P*
Hospitals (n) 308 231 61 16 —
Teaching hospital (%) 50.0 43.7 67.2 75.0 .001
Hospital size per no. of beds (%)
Small 6.9 7.4 6.7 0
Medium 23.2 27.7 10.0 6.7
Large 69.9 64.9 83.3 93.3 .012
Geographic region (%)
Northeast 20.1 18.2 28.3 16.7
Midwest 23.7 24.9 20.7 16.7
South 32.1 32.0 30.2 41.6
West 24.1 24.9 20.8 25.0 .774
TAAA, Thoracoabdominal aortic aneurysm.
*Pearson 2 test.
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tions. The multivariate model of mortality was tested for
goodness of fit according to the Hosmer-Lemeshow meth-
od.17 P  .05 was considered statistically significant in all
final analyses. SPSS software (version 11.0; SPSS, Chicago,
Ill) was used for all statistical analysis and graphing.
RESULTS
Overall mortality after TAAA repair was 22.3% in this
series of 1542 patients. A significant improvement in mor-
tality was observed from 1988 to 1998 (P .002) (Fig 1).
Mean (SD) patient age was 68.4 (9.7) years. Patient age
was similar for hospitals with varying procedural volume
(Table II). Men outnumbered women 59% to 41%. Most
patients were white, and a higher rate of white patients
received treatment at HVH. Most patients had at least one
comorbid condition. Total comorbid disease burden was
similar in the three hospital volume categories.
Mortality varied significantly for patients on the basis of
hospital caseload volume (Fig 2). LVH had a 27.3% mor-
tality rate, compared with 15.0% at HVH (P  .001) and
23.8% at MVH (P .001) (Fig 2). Significant difference in
mortality was also observed for surgeon volume (Fig 3).
LVS had a 25.6% mortality rate, compared with 11.0% for
HVS (P  .001). Subgroup analysis based on patient age
revealed a significant variation in mortality by provider
volume (Table III). Patients younger than 65 years experi-
enced a 21.5% mortality rate at LVH, compared with 8.6%
at HVH (P  .005). The difference in treating patients
younger than 65 years was even greater between LVS and
HVS: 21.0% and 3.4%, respectively (P  .001).
Median postoperative LOS was shorter for non-surviv-
ing patients compared with surviving patients (Table IV).
Surviving patients at HVH had longer LOS (P  .004).
Perioperative death rate within 24 hours of surgery was
significantly different: 27.6% for HVH, compared with
30.6% for MVH and 42.3% for LVH (P  .041).
More than half of all patients had at least one postop-
erative complication after repair of an intact TAAA (Table
V). On average, HVH had a higher rate of total postoper-
ative complications compared with lower volume centers.
HVH had a significantly higher rate of pulmonary compli-
cations compared with MVH or LVH (P  .033), and
MVH had a higher rate of acute renal failure (P  .028).
Other complications had similar rates of occurrence be-
tween hospitals with varying procedural volume.
Binary logistic regression models identified predictors
of postoperative mortality (Table VI). Hospital volume and
surgeon volume were entered in separate models. Signifi-
cant risk factors for mortality included postoperative hem-
orrhage (odds ratio [OR] 4.4; 95% confidence interval [CI]
3.1-6.2; P  .001), acute renal failure (OR 3.5; 95% CI
2.4-5.0; P  .001), postoperative cardiac complications
(OR 3.0; 95% CI 2.1-4.2; P .001), LVS (OR 2.6; 95% CI
1.7-4.1; P  .001), LVH (OR 2.2; 95% CI 1.6-3.1; P 
.001), MVH (OR 1.7; 95% CI 1.2-2.4; P  .004), age 65
years or older (OR 1.6; 95% CI 1.2-2.2; P  .003),
Fig 1. In-hospital mortality rate after TAAA surgical repair from 1988 to 1998 in the United States. Comparing
1988-1993 with 1994-1998, mortality rate improved 25.7% to 19.3% (P  .002).
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nonwhite race (OR 1.5; 95% CI 1.1-1.9; P  .009), and
emergent admission (OR 1.4; 95% CI 1.1-1.9; P  .006).
DISCUSSION
Provider caseload volume, as defined in this study, was
a valid predictor of postoperative mortality after repair of
intact TAAAs. The present investigation documented that
patients with TAAAs treated at HVH and by HVS had a
42% and a 58% reduction in mortality, respectively. These
data further suggest that patients younger than 65 years
with intact TAAAs may benefit even more from referral to
HVH and HVS. These differences persisted despite adjust-
ment for patient demographic data, comorbid conditions,
and inclusion of postoperative complications.
Median LOS for surviving patients increased minimally
at HVH. This may reflect a more complicated postopera-
tive course. Of importance, more than 40% of patients who
died at LVH had LOS less than 24 hours. This was signif-
icantly different from that at higher volume hospitals and
indicates that differences exist in perioperative manage-
ment of these patients. Most patients had at least one
postoperative complication after TAAA repair. Pulmonary,
cardiac, and renal complications were most common at all
hospitals.
Outcome for higher volume providers observed in this
study is consistent with contemporary large single-institution
reports. Coselli et al3 reported a 4.8% mortality rate for TAAA
repair. Increasing age, renal insufficiency, and symptomatic
Table II. Demographic data for patients who underwent repair of intact TAAAs in the United States from 1988 to
1998
Annual hospital TAAA repair volume (median number of operations)
Total Low (1) Medium (4) High (12) P*
Patients (n) 1,542 569 467 506 —
Age (y), mean (SD) 68.4(9.7) 68.5(9.9) 68.3(9.9) 68.3(9.2) .970†
Male gender (%) 59 60 58 58 .731
White race (%) 66 57 63 78 .001
Comorbidity score‡ (%)
0 2.7 4.2 1.7 2.0 .022
1 68.0 65.5 72.2 66.8 .060
2 26.1 27.3 23.3 27.3 .274
3 3.2 3.0 2.8 4.0 .597
Comparisons are made between hospitals with varying procedural volume.
TAAA, Thoracoabdominal aortic aneurysm.
*Pearson 2 test unless otherwise noted.
†Analysis of variance.
‡Scores represent total number of cardiovascular, pulmonary, hepatic, renal, and malignant conditions present.
Fig 2. Variation in mortality by hospital volume after surgical
repair of intact TAAAs. P  .001, Pearson 2 test.
Fig 3. Variation in mortality by surgeon volume after repair of
intact TAAAs. P  .001, Pearson 2 test.
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enlargement were predictive of worse outcome in the former
experience. This same group reported a 10% mortality for type
II TAAA.4 In 1509 patients undergoing TAAA operations,
Svensson et al5 reported an 8% postoperative mortality. Cam-
bria et al6 reported an 8.3% operative mortality in 337 consec-
utive patients undergoing TAAA repair from 1987 to 2001.
Urgent or emergent operation was associated with increased
risk for death, whereas age more than 70 years was not
predictive of operative mortality. In a different patient sample,
Rectenwald et al7 reported a 10% postoperative mortality for
elective repair and a 28% mortality for urgent TAAA repair.
These latter authors observed at least one postoperative com-
plication in most patients, a finding similar to that of the
present study. Estrera et al8 observed a 16% in-hospital post-
operative mortality in their series of 654 patients. This group
also found increased but acceptable mortality for patients 79
years or older.18
The reasons for a direct provider volume effect on
outcome after TAAA repair are not well defined. Dimick et
al19 demonstrated that differences in rate of postoperative
complications after AAA repair contributed significantly to
volume-outcome effect. By reducing these complications,
differences in mortality might be narrowed among provid-
ers with differing procedural volume. Data from the present
Table III. Subgroup analysis of postoperative mortality based on patient age after intact TAAA repair in the United
States from 1988 to 1998
Annual hospital TAAA repair volume
(median number of operations)
Annual surgeon TAAA repair volume (median
number of operations)
Total Low (1) Medium (4) High (12) P* Total Low (1) High (7) P*
Patient age
65 y (%) 17.1 21.5 20.6 8.6 .005 14.9 21.0 3.4 .001
(75/438) (37/172) (26/126) (12/140) (37/249) (34/162) (3/87)
65 y (%) 24.3 30.0 24.9 17.5 .001 21.7 27.7 13.6 .001
(268/1104) (119/397) (85/341) (64/388) (185/853) (96/346) (34/248)
Comparisons are made between hospitals and surgeons with varying procedural volume.
TAAA, Thoracoabdominal aortic aneurysm.
*Pearson 2 test.
Table IV. Postoperative LOS by hospital volume for patients who underwent surgical repair of intact TAAAs in the
United States from 1988 to 1998
Annual hospital TAAA repair volume (median number of operations)
Total Low (1) Medium (4) High (12) P*
Median LOS/(IQR) (d)†
Surviving 12 (8-19) 11 (8-18) 13 (8-21) 12 (9-20) .004
Not surviving 5 (1-16) 3 (0-14) 6 (1-17) 7 (1-18) .101
LOS 24 hr (% total deaths) 35.3 42.3 30.6 27.6 .041
TAAA, Thoracoabdominal aortic aneurysm; LOS, length of stay; IQR, interquartile range.
*Kruskal-Wallis test, unless otherwise indicated.
†IQR (25th to 75th percentile) for LOS.
‡Pearson 2 test.
Table V. Postoperative complications by hospital volume for patients who underwent repair of intact TAAAs in the
United States from 1988 to 1998
Annual hospital TAAA repair volume (median number of operations)
Total Low (1) Medium (4) High (12) P*
Any complication (%) 55.2 51.5 56.8 57.9 .078
Cardiac (%) 14.8 12.8 13.9 17.8 .060
Pulmonary (%) 19.0 17.4 16.9 22.7 .033
Urinary tract (%) 9.9 7.7 10.5 11.7 .084
Hemorrhage (%) 12.4 14.8 11.8 10.3 .074
Acute renal failure (%) 14.2 12.3 17.8 13.0 .028
TAAA, Thoracoabdominal aortic aneurysm.
*Pearson 2 test.
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study suggest that postoperative complications contribute
to mortality but do not completely explain observed differ-
ences in outcome. For example, when complications are
included in the regression model, volume variables do not
lose significance. The high rate of death within the first 24
hours experienced with lower volume providers suggests
that important operative and immediate postoperative haz-
ards may occur in their patients. This may provide more
impetus to refer patients to centers with the latest in surgi-
cal techniques, monitoring, and anesthesia, and a multidis-
ciplinary approach to postoperative management.
The present study has certain limitations. First, the nature
of administrative data precludes determination of certain vari-
ables, eg, aneurysm type, blood loss, hemodynamic status,
cross-clamp time, spinal drainage, and aortic distal perfusion,
which may influence outcome. Second, determination of
mortality was made during an index postoperative hospitaliza-
tion. Therefore difference in long-term mortality between
various providers is unknown. Finally, determination of post-
operative complications and comorbid conditions relies on
secondary diagnostic codes, which may not be recorded with
100% accuracy or contain information regarding severity. This
may explain, for example, the inability of certain postoperative
complications or comorbid conditions to predict mortality in
this population. There is no evidence, however, that provider
volume affects coding of these variables. Thus relative differ-
ences between groups should be accurate.
Despite incremental improvement in outcome after
intact TAAA repair from 1988 to 1998, overall mortality in
the United States continues to be higher than that com-
monly published in selected single institutional series. The
relative infrequency of TAAA and the fact that most are
intact at presentation, coupled with large variation in out-
come between providers with different caseload volume,
suggests that regionalization of these complex surgical proce-
dures may be practical and in the patient’s best interest.
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Table VI. Binary logistic regression model for
postoperative mortality after TAAA repair
Risk factors Odds ratio
95% confidence
interval P*
Emergent/urgent admission 1.4 1.1-1.9 .006
Age 65 (y) 1.6 1.2-2.2 .003
Female gender .87 0.67-1.1 .318
Nonwhite race 1.5 1.1-1.9 .009
Comorbidity score†
1 0.90 0.40-2.0 .796
2 0.89 0.38-2.0 .774
3 2.1 0.77-5.9 .147
Postoperative complication
Cardiac 3.0 2.1-4.2 .001
Pulmonary 0.48 0.33-0.71 .001
Urinary 1.2 .77-1.9 .443
Hemorrhage 4.4 3.1-6.2 .001
Acute renal failure 3.5 2.4-5.0 .001
Hospital volume
Low (median, 1 case) 2.2 1.6-3.1 .001
Medium (median, 4 cases) 1.7 1.2-2.4 .004
Low surgeon volume‡
(median, 1 case)
2.6 1.7-4.1 .001
TAAA, Thoracoabdominal aortic aneurysm.
*Hosmer-Lemeshow test, X  4.8, P  .777.
†Reference group is a comorbidity score  0.
‡Surgeon volume and hospital volume variables were run in separate regres-
sion models.
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